3D Systems Corp banner

3D Systems Corp
BMV:DDD

Watchlist Manager
3D Systems Corp Logo
3D Systems Corp
BMV:DDD
Watchlist
Price: 60.9 MXN -0.98% Market Closed
Market Cap: Mex$418.6m

3D Systems Corp
Investor Relations

3D Systems Corp makes 3D printers, printing materials, software, and related services. Its machines turn digital designs into physical parts by building them layer by layer from plastics, metals, and other materials. The company sells to industrial customers that need prototypes, custom parts, tooling, and small production runs. Its main customers include aerospace, healthcare, automotive, electronics, and manufacturing companies, along with dental and medical practices that use 3D printing for models, devices, and patient-specific products. 3D Systems also helps customers with application design, part production, and workflow setup, which makes it more than just a hardware seller. The company makes money by selling printers, materials, software, maintenance, and manufacturing services. That mix matters because 3D printing is a workflow business: once a customer installs a printer, it often keeps buying compatible materials and support from the same vendor. 3D Systems sits in the middle of the additive manufacturing chain, connecting design, equipment, and end-use production.

Show more
Loading...
DDD
Mexico S&P/BMV IPC
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
May 12, 2026
AI Summary
Q1 2026

Top line: 3D Systems said Q1 2026 was a strong quarter, with revenue up 11% year over year and growth across its key healthcare and industrial end markets.

Profitability: Gross margin improved sharply and adjusted EBITDA turned positive at $2.1 million, helped by higher volumes, better mix and prior cost cuts.

Demand: Management sounded more optimistic than in past years, saying the industry is emerging from a long downturn and demand is broadening in Dental, Med Tech and Aerospace & Defense.

Dental momentum: The NextDent 300 denture platform is seeing strong early traction, with a major U.S. lab deployment and EU approval arriving 2 months ahead of schedule.

Guidance: Q2 revenue guidance was set at $93 million to $95 million and adjusted EBITDA at a loss of $2 million to $4 million, with management taking a cautious stance because of seasonality and global volatility.

Full-year goal: The company still expects to reach adjusted EBITDA breakeven or better for the full year.

Cost discipline: More than $55 million in annualized cost savings have been delivered so far, and the remaining cost reduction program is expected to finish by the end of Q2.

Key Financials
Revenue
$95.5 million
Industrial Solutions revenue
$45.4 million
Healthcare Solutions revenue
$50.1 million
Gross margin
36.1%
Operating expenses
$36.6 million
Adjusted EBITDA
$2.1 million
Loss per share
$0.01
Cash
$86.5 million
Cash and cash equivalents
$85.1 million
Restricted cash
$1.4 million
Debt due in 2026
$3.9 million
Debt maturing in 2030
$92 million
Annualized cost savings
more than $55 million
Aerospace & Defense growth
over 20%
Littleton expansion
80,000 square feet
Addressable market for denture platform
more than 60 million edentulous patients
EU denture approval timing
2 months ahead of schedule
Earnings Call Recording
Other Earnings Calls

Management

Dr. Jeffrey Alan Graves Ph.D.
President, CEO & Director
No Bio Available
Mr. Reji Puthenveetil
Executive Vice President of Industrial Solutions, Additive Solutions & Chief Commercial Officer
No Bio Available
Mr. Jeffrey D. Creech
Executive VP, Principal Accounting Officer & CFO
No Bio Available
Ms. Phyllis B. Nordstrom
Executive VP, Chief People Officer & Chief Administrative Officer
No Bio Available
Dr. Charles W. Hull
Co-Founder, Executive VP, CTO of Regenerative Medicine & Director Emeritus
No Bio Available
Dr. Joseph Zuiker
Executive Vice President of Engineering & Operations
No Bio Available
Mr. Michael McCloskey
Treasurer & VP of Investor Relations
No Bio Available
Mr. Andrew W.B. Wright J.D.
Senior VP of General Counsel & Corporate Secretary
No Bio Available
Mr. Harriss T. Currie
President - Regenerative Medicine
No Bio Available

Contacts

Address
SOUTH CAROLINA
Rock Hill
333 Three D Systems Cir
Contacts
+18033263900.0
www.3dsystems.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett